Chinanews, April 14th, comprehensive report, in view of the United States has reported 6 cases of rare severe thrombosis due to vaccination of Johnson & Johnson's new crown vaccine, the US health authority issued a statement on the 13th, recommending that the vaccination be suspended.

Up to now, approximately 20 states in the United States have suspended Johnson & Johnson vaccination.

How will this affect the vaccination process in the United States?

　　Affected by the US decision, South Africa also announced the suspension of Johnson & Johnson vaccination, and EU officials have expressed close attention to this.

The picture shows a rider wearing a mask riding on the Brooklyn Bridge in New York.

The United States, South Africa suspend Johnson & Johnson vaccination

The EU pays close attention

　　According to reports, Johnson & Johnson vaccine is the third vaccine approved for emergency use in the United States.

According to the US Centers for Disease Control and Prevention (CDC), 6.8 million people in the United States have been vaccinated with the vaccine, and 9 million doses have been distributed to states.

Up to now, 6 cases of "cerebral venous sinus thrombosis" have been reported.

　　The CDC and the U.S. Food and Drug Administration (FDA) said on the 13th that the decision was “out of cautious considerations.” Although the number of reported thrombosis cases is very small, it is recommended to suspend injections to give doctors time to understand how to treat potential side effect.

　　FDA Acting Commissioner Janet Woodcock said at the briefing that she expects the suspension of the proposal to last only "a few days."

Fauci, director of the National Institute of Allergy and Infectious Diseases, also said that the Johnson & Johnson vaccine is expected to be put back into use after investigation.

　　As of the 13th, 19 states, including New York, Connecticut, Massachusetts, and New Jersey, have announced suspension of vaccinations against Johnson & Johnson.

　　Affected by this, the South African Ministry of Health stated on the 13th that South Africa will suspend vaccination of Johnson & Johnson vaccine "until the causal relationship between thrombosis and Johnson & Johnson vaccine is fully investigated."

According to reports, nearly 300,000 people in the country have been vaccinated against Johnson & Johnson, but there has been no report of thrombosis.

　　The European Commission’s Commissioner for Health and Food Safety Kiriya Kidis also said on the same day that he was paying close attention to the issue of Johnson & Johnson's new crown vaccine.

Johnson & Johnson has stated that it will take the initiative to suspend the supply of vaccines to Europe.

On February 24, local time, the American flag in Times Square, New York, USA was lowered at half mast.

On February 22, U.S. President Biden issued an announcement ordering all federal buildings and military installations inside and outside the United States to fly at half-mast for a period of five days to mourn the deaths of the new crown.

Photo by China News Agency reporter Liao Pan

Will the US vaccination process be affected?

Biden responds

　　The New York Times pointed out that after the suspension of Johnson & Johnson vaccination, the United States may face a vaccine gap of about 30 million doses; The Washington Post said that the suspension of Johnson & Johnson vaccination may delay the U.S. response to the epidemic because of the surge in cases in Michigan. "Shocking", and the epidemic curve is showing an upward trend across the United States.

　　In response to concerns about the supply of new crown vaccines, on the 13th local time, US President Biden responded that the nationwide supply is now enough to vaccinate "every American".

He said, "I make sure we have 600 million doses of the new crown vaccine, not Johnson & Johnson and AstraZeneca."

　　At present, parts of New York State and California have announced that those who have previously made appointments for Johnson & Johnson vaccines at vaccination sites will be vaccinated with Pfizer or Modena's new crown vaccine.

　　The CEO of Pfizer said on the 13th that the company has accelerated the pace of vaccine production and will complete the delivery target ahead of schedule.

The company was originally scheduled to complete the delivery target of 300 million new crown vaccines in mid-August, which may be completed two weeks in advance.

In addition, the supply before the end of May will also be 10% higher than originally planned.